Vaxxinity reports third quarter 2023 financial results and provides corporate update

Cape canaveral, fla., nov. 08, 2023 (globe newswire) -- vaxxinity, inc. (nasdaq: vaxx), a u.s. company pioneering the development of a new class of medicines, today reported financial results for the third quarter ended september 30, 2023, and provided a corporate update.

VAXX Ratings Summary

VAXX Quant Ranking